Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Coexpression of p-IGF-1R and MMP-7 Modulates Panitumumab and Cetuximab Efficacy in RAS Wild-Type Metastatic Colorectal Cancer Patients.

Alonso V, Escudero P, Fernández-Martos C, Salud A, Méndez M, Gallego J, Rodriguez JR, Martín-Richard M, Fernández-Plana J, Manzano H, Méndez JC, Zanui M, Falcó E, Gil-Raga M, Rojo F, Cuatrecasas M, Feliu J, García-Albéniz X, Maurel J.

Neoplasia. 2018 May 25;20(7):678-686. doi: 10.1016/j.neo.2018.05.004. [Epub ahead of print]

2.

Dielectric properties of colon polyps, cancer, and normal mucosa: Ex vivo measurements from 0.5 to 20 GHz.

Guardiola M, Buitrago S, Fernández-Esparrach G, O'Callaghan JM, Romeu J, Cuatrecasas M, Córdova H, González Ballester MÁ, Camara O.

Med Phys. 2018 May 28. doi: 10.1002/mp.13016. [Epub ahead of print]

PMID:
29807391
3.

Near-tetraploid cancer cells show chromosome instability triggered by replication stress and exhibit enhanced invasiveness.

Wangsa D, Quintanilla I, Torabi K, Vila-Casadesús M, Ercilla A, Klus G, Yuce Z, Galofré C, Cuatrecasas M, Lozano JJ, Agell N, Cimini D, Castells A, Ried T, Camps J.

FASEB J. 2018 Feb 8:fj201700247RR. doi: 10.1096/fj.201700247RR. [Epub ahead of print]

PMID:
29452566
4.

Rare germline copy number variants in colorectal cancer predisposition characterized by exome sequencing analysis.

Franch-Expósito S, Esteban-Jurado C, Garre P, Quintanilla I, Duran-Sanchon S, Díaz-Gay M, Bonjoch L, Cuatrecasas M, Samper E, Muñoz J, Ocaña T, Carballal S, López-Cerón M, Castells A; EPICOLON consortium, Vila-Casadesús M, Derdak S, Laurie S, Beltran S, Carvajal J, Bujanda L, Ruiz-Ponte C, Camps J, Gironella M, Lozano JJ, Balaguer F, Cubiella J, Caldés T, Castellví-Bel S.

J Genet Genomics. 2018 Jan 20;45(1):41-45. doi: 10.1016/j.jgg.2017.12.001. Epub 2017 Dec 20. No abstract available.

PMID:
29396139
5.

Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer.

Codony-Servat J, Cuatrecasas M, Asensio E, Montironi C, Martínez-Cardús A, Marín-Aguilera M, Horndler C, Martínez-Balibrea E, Rubini M, Jares P, Reig O, Victoria I, Gaba L, Martín-Richard M, Alonso V, Escudero P, Fernández-Martos C, Feliu J, Méndez JC, Méndez M, Gallego J, Salud A, Rojo F, Castells A, Prat A, Rosell R, García-Albéniz X, Camps J, Maurel J.

Br J Cancer. 2017 Dec 5;117(12):1777-1786. doi: 10.1038/bjc.2017.279. Epub 2017 Nov 9.

PMID:
29123263
6.

Transanal total mesorectal excision: pathological results of 186 patients with mid and low rectal cancer.

de Lacy FB, van Laarhoven JJEM, Pena R, Arroyave MC, Bravo R, Cuatrecasas M, Lacy AM.

Surg Endosc. 2018 May;32(5):2442-2447. doi: 10.1007/s00464-017-5944-8. Epub 2017 Nov 3.

PMID:
29101570
7.

Increased IFRD1 Expression in Human Colon Cancers Predicts Reduced Patient Survival.

Lewis MA, Sharabash N, Miao ZF, Lyons LN, Piccirillo J, Kallogjeri D, Schootman M, Mutch M, Yan Y, Levin MS, Castells A, Cuatrecasas M, Mills JC, Wang ZN, Rubin DC.

Dig Dis Sci. 2017 Dec;62(12):3460-3467. doi: 10.1007/s10620-017-4819-0. Epub 2017 Nov 1.

PMID:
29094309
8.

Serrated polyposis syndrome associated with long-standing inflammatory bowel disease.

Castro J, Cuatrecasas M, Balaguer F, Ricart E, Pellisé M.

Rev Esp Enferm Dig. 2017 Nov;109(11):796-798. doi: 10.17235/reed.2017.5068/2017.

9.

Efficacy and safety of a combination of hyaluronic acid, chondroitin sulfate, and poloxamer 407 as a submucosal injection solution for endoscopic resection: pilot study on a swine model.

Fernández-Esparrach G, Cuatrecasas M, Rodríguez de Miguel C, Sánchez-Montes C, Córdova H.

Endosc Int Open. 2017 Jun;5(6):E450-E454. doi: 10.1055/s-0043-107614. Epub 2017 May 31.

10.

Gene expression study and pathway analysis of histological subtypes of intestinal metaplasia that progress to gastric cancer.

Companioni O, Sanz-Anquela JM, Pardo ML, Puigdecanet E, Nonell L, García N, Parra Blanco V, López C, Andreu V, Cuatrecasas M, Garmendia M, Gisbert JP, Gonzalez CA, Sala N.

PLoS One. 2017 Apr 25;12(4):e0176043. doi: 10.1371/journal.pone.0176043. eCollection 2017.

11.

POLE and POLD1 screening in 155 patients with multiple polyps and early-onset colorectal cancer.

Esteban-Jurado C, Giménez-Zaragoza D, Muñoz J, Franch-Expósito S, Álvarez-Barona M, Ocaña T, Cuatrecasas M, Carballal S, López-Cerón M, Marti-Solano M, Díaz-Gay M, van Wezel T, Castells A, Bujanda L, Balmaña J, Gonzalo V, Llort G, Ruiz-Ponte C, Cubiella J, Balaguer F, Aligué R, Castellví-Bel S.

Oncotarget. 2017 Apr 18;8(16):26732-26743. doi: 10.18632/oncotarget.15810.

12.

Increased Risk of Colorectal Cancer in Patients With Multiple Serrated Polyps and Their First-Degree Relatives.

Egoavil C, Juárez M, Guarinos C, Rodríguez-Soler M, Hernández-Illán E, Alenda C, Payá A, Castillejo A, Serradesanferm A, Bujanda L, Fernández-Bañares F, Cubiella J, de-Castro L, Guerra A, Aguirre E, Herreros-de-Tejada A, Bessa X, Herráiz M, Marín-Gabriel JC, Balmaña J, Piñol V, Rodríguez Moranta F, Nicolás-Pérez D, Cuatrecasas M, Balaguer F, Castells A, Soto JL, Zapater P, Jover R.

Gastroenterology. 2017 Jul;153(1):106-112.e2. doi: 10.1053/j.gastro.2017.04.003. Epub 2017 Apr 9.

PMID:
28400194
13.

Lymph node pooling: a feasible and efficient method of lymph node molecular staging in colorectal carcinoma.

Rakislova N, Montironi C, Aldecoa I, Fernandez E, Bombi JA, Jimeno M, Balaguer F, Pellise M, Castells A, Cuatrecasas M.

J Transl Med. 2017 Jan 14;15(1):14. doi: 10.1186/s12967-016-1114-3.

14.

Reassessment colonoscopy to diagnose serrated polyposis syndrome in a colorectal cancer screening population.

Rivero-Sanchez L, Lopez-Ceron M, Carballal S, Moreira L, Bessa X, Serradesanferm A, Pozo A, Augé JM, Ocaña T, Sánchez A, Leoz ML, Cuatrecasas M, Grau J, Llach J, Castells A, Balaguer F, Pellisé M; Procolon Group.

Endoscopy. 2017 Jan;49(1):44-53. doi: 10.1055/s-0042-115640. Epub 2016 Oct 14.

PMID:
27741536
15.

[Recommendations for the diagnosis, staging and treatment of pre-malignant lesions and pancreatic adenocarcinoma].

Martin-Richard M, Ginès A, Ayuso JR, Sabater L, Fabregat J, Mendez R, Fernández-Esparrach G, Molero X, Vaquero EC, Cuatrecasas M, Ferrández A, Maurel J; Comité multidisciplinar para la actualización de las recomendaciones para el manejo de las lesiones pre-malignas y el adenocarcinoma de páncreas.

Med Clin (Barc). 2016 Nov 18;147(10):465.e1-465.e8. doi: 10.1016/j.medcli.2016.07.033. Epub 2016 Oct 7. Spanish.

PMID:
27726847
16.

Real-life chromoendoscopy for neoplasia detection and characterisation in long-standing IBD.

Carballal S, Maisterra S, López-Serrano A, Gimeno-García AZ, Vera MI, Marín-Garbriel JC, Díaz-Tasende J, Márquez L, Álvarez MA, Hernández L, De Castro L, Gordillo J, Puig I, Vega P, Bustamante-Balén M, Acevedo J, Peñas B, López-Cerón M, Ricart E, Cuatrecasas M, Jimeno M, Pellisé M; EndoCAR group of the Spanish Gastroenterological Association and Spanish Digestive Endoscopy Society.

Gut. 2018 Jan;67(1):70-78. doi: 10.1136/gutjnl-2016-312332. Epub 2016 Sep 9.

PMID:
27612488
17.

Molecularly determined total tumour load in lymph nodes of stage I-II colon cancer patients correlates with high-risk factors. A multicentre prospective study.

Aldecoa I, Atares B, Tarragona J, Bernet L, Sardon JD, Pereda T, Villar C, Mendez MC, Gonzalez-Obeso E, Elorriaga K, Alonso GL, Zamora J, Planell N, Palacios J, Castells A, Matias-Guiu X, Cuatrecasas M.

Virchows Arch. 2016 Oct;469(4):385-94. doi: 10.1007/s00428-016-1990-1. Epub 2016 Jul 22.

18.

Phase II randomised trial of autologous tumour lysate dendritic cell plus best supportive care compared with best supportive care in pre-treated advanced colorectal cancer patients.

Caballero-Baños M, Benitez-Ribas D, Tabera J, Varea S, Vilana R, Bianchi L, Ayuso JR, Pagés M, Carrera G, Cuatrecasas M, Martin-Richard M, Cid J, Lozano M, Castells A, García-Albéniz X, Maurel J, Vilella R.

Eur J Cancer. 2016 Sep;64:167-74. doi: 10.1016/j.ejca.2016.06.008. Epub 2016 Jul 16.

PMID:
27428073
19.

Phosphorylated-insulin growth factor I receptor (p-IGF1R) and metalloproteinase-3 (MMP3) expression in advanced gastrointestinal stromal tumors (GIST). A GEIS 19 study.

Maurel J, López-Pousa A, Calabuig S, Bagué S, Del Muro XG, Sanjuan X, Rubió-Casadevall J, Cuatrecasas M, Martinez-Trufero J, Horndler C, Fra J, Valverde C, Redondo A, Poveda A, Sevilla I, Lainez N, Rubini M, García-Albéniz X, Martín-Broto J, de Alava E.

Clin Sarcoma Res. 2016 Jun 29;6:10. doi: 10.1186/s13569-016-0050-6. eCollection 2016.

20.

Endoscopic tattooing of early colon carcinoma enhances detection of lymph nodes most prone to harbor tumor burden.

Aldecoa I, Montironi C, Planell N, Pellise M, Fernandez-Esparrach G, Gines A, Delgado S, Momblan D, Moreira L, Lopez-Ceron M, Rakislova N, Martinez-Palli G, Balust J, Bombi JA, de Lacy A, Castells A, Balaguer F, Cuatrecasas M.

Surg Endosc. 2017 Feb;31(2):723-733. doi: 10.1007/s00464-016-5026-3. Epub 2016 Jun 20.

21.

MicroRNAs for Detection of Pancreatic Neoplasia: Biomarker Discovery by Next-generation Sequencing and Validation in 2 Independent Cohorts.

Vila-Navarro E, Vila-Casadesús M, Moreira L, Duran-Sanchon S, Sinha R, Ginés À, Fernández-Esparrach G, Miquel R, Cuatrecasas M, Castells A, Lozano JJ, Gironella M.

Ann Surg. 2017 Jun;265(6):1226-1234. doi: 10.1097/SLA.0000000000001809.

22.

The Fanconi anemia DNA damage repair pathway in the spotlight for germline predisposition to colorectal cancer.

Esteban-Jurado C, Franch-Expósito S, Muñoz J, Ocaña T, Carballal S, López-Cerón M, Cuatrecasas M, Vila-Casadesús M, Lozano JJ, Serra E, Beltran S, Brea-Fernández A, Ruiz-Ponte C, Castells A, Bujanda L, Garre P, Caldés T, Cubiella J, Balaguer F, Castellví-Bel S.

Eur J Hum Genet. 2016 Oct;24(10):1501-5. doi: 10.1038/ejhg.2016.44. Epub 2016 May 11.

23.

Incomplete type of intestinal metaplasia has the highest risk to progress to gastric cancer: results of the Spanish follow-up multicenter study.

González CA, Sanz-Anquela JM, Companioni O, Bonet C, Berdasco M, López C, Mendoza J, Martín-Arranz MD, Rey E, Poves E, Espinosa L, Barrio J, Torres MÁ, Cuatrecasas M, Elizalde I, Bujanda L, Garmendia M, Ferrández Á, Muñoz G, Andreu V, Paules MJ, Lario S, Ramírez MJ; Study group, Gisbert JP.

J Gastroenterol Hepatol. 2016 May;31(5):953-8. doi: 10.1111/jgh.13249.

PMID:
26630310
24.

Enteric nervous system α-synuclein immunoreactivity in idiopathic REM sleep behavior disorder.

Sprenger FS, Stefanova N, Gelpi E, Seppi K, Navarro-Otano J, Offner F, Vilas D, Valldeoriola F, Pont-Sunyer C, Aldecoa I, Gaig C, Gines A, Cuatrecasas M, Högl B, Frauscher B, Iranzo A, Wenning GK, Vogel W, Tolosa E, Poewe W.

Neurology. 2015 Nov 17;85(20):1761-8. doi: 10.1212/WNL.0000000000002126. Epub 2015 Oct 16.

25.

Postoperative complications do not impact on recurrence and survival after curative resection of gastric cancer.

Climent M, Hidalgo N, Vidal Ó, Puig S, Iglesias M, Cuatrecasas M, Ramón JM, García-Albéniz X, Grande L, Pera M.

Eur J Surg Oncol. 2016 Jan;42(1):132-9. doi: 10.1016/j.ejso.2015.08.163. Epub 2015 Sep 3.

PMID:
26385054
26.

Colorectal cancer risk factors in patients with serrated polyposis syndrome: a large multicentre study.

Carballal S, Rodríguez-Alcalde D, Moreira L, Hernández L, Rodríguez L, Rodríguez-Moranta F, Gonzalo V, Bujanda L, Bessa X, Poves C, Cubiella J, Castro I, González M, Moya E, Oquiñena S, Clofent J, Quintero E, Esteban P, Piñol V, Fernández FJ, Jover R, Cid L, López-Cerón M, Cuatrecasas M, López-Vicente J, Leoz ML, Rivero-Sánchez L, Castells A, Pellisé M, Balaguer F; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association.

Gut. 2016 Nov;65(11):1829-1837. doi: 10.1136/gutjnl-2015-309647. Epub 2015 Aug 11.

PMID:
26264224
27.

Let-7 Represses Carcinogenesis and a Stem Cell Phenotype in the Intestine via Regulation of Hmga2.

Madison BB, Jeganathan AN, Mizuno R, Winslow MM, Castells A, Cuatrecasas M, Rustgi AK.

PLoS Genet. 2015 Aug 5;11(8):e1005408. doi: 10.1371/journal.pgen.1005408. eCollection 2015 Aug.

28.

Alpha-synuclein immunoreactivity patterns in the enteric nervous system.

Aldecoa I, Navarro-Otano J, Stefanova N, Sprenger FS, Seppi K, Poewe W, Cuatrecasas M, Valldeoriola F, Gelpi E, Tolosa E.

Neurosci Lett. 2015 Aug 18;602:145-9. doi: 10.1016/j.neulet.2015.07.005. Epub 2015 Jul 7.

PMID:
26163460
29.

Erratum: Different thresholds of ZEB1 are required for Ras-mediated tumour initiation and metastasis.

Liu Y, Lu X, Huang L, Wang W, Jiang G, Dean KC, Clem B, Telang S, Jenson AB, Cuatrecasas M, Chesney J, Darling DS, Postigo A, Dean DC.

Nat Commun. 2015 Mar 19;6:6699. doi: 10.1038/ncomms7699. No abstract available.

PMID:
25789446
30.

Pitfalls in the diagnosis of biallelic PMS2 mutations.

Antelo M, Milito D, Rhees J, Roca E, Barugel M, Cuatrecasas M, Moreira L, Leoz ML, Carballal S, Ocaña T, Pellisé M, Castells A, Boland CR, Goel A, Balaguer F.

Fam Cancer. 2015 Sep;14(3):411-4. doi: 10.1007/s10689-015-9793-0.

PMID:
25773960
31.

Corrigendum: Characterization of inflammation and fibrosis in Crohn's disease lesions by magnetic resonance imaging.

Rimola J, Planell N, Rodríguez S, Delgado S, Ordás I, Ramírez-Morros A, Ayuso C, Aceituno M, Ricart E, Jauregui-Amezaga A, Panés J, Cuatrecasas M.

Am J Gastroenterol. 2015 Mar;110(3):480. doi: 10.1038/ajg.2015.40. No abstract available.

PMID:
25743724
32.

Characterization of inflammation and fibrosis in Crohn's disease lesions by magnetic resonance imaging.

Rimola J, Planell N, Rodríguez S, Delgado S, Ordás I, Ramírez-Morros A, Ayuso C, Aceituno M, Ricart E, Jauregui-Amezaga A, Panés J, Cuatrecasas M.

Am J Gastroenterol. 2015 Mar;110(3):432-40. doi: 10.1038/ajg.2014.424. Epub 2015 Jan 27. Erratum in: Am J Gastroenterol. 2015 Mar;110(3):480.

PMID:
25623654
33.

Prevalence of somatic mutl homolog 1 promoter hypermethylation in Lynch syndrome colorectal cancer.

Moreira L, Muñoz J, Cuatrecasas M, Quintanilla I, Leoz ML, Carballal S, Ocaña T, López-Cerón M, Pellise M, Castellví-Bel S, Jover R, Andreu M, Carracedo A, Xicola RM, Llor X, Boland CR, Goel A, Castells A, Balaguer F; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association.

Cancer. 2015 May 1;121(9):1395-404. doi: 10.1002/cncr.29190. Epub 2014 Dec 29.

34.

Different thresholds of ZEB1 are required for Ras-mediated tumour initiation and metastasis.

Liu Y, Lu X, Huang L, Wang W, Jiang G, Dean KC, Clem B, Telang S, Jenson AB, Cuatrecasas M, Chesney J, Darling DS, Postigo A, Dean DC.

Nat Commun. 2014 Dec 1;5:5660. doi: 10.1038/ncomms6660. Erratum in: Nat Commun. 2015;6:6699.

PMID:
25434817
35.

Adjuvant therapy sparing in rectal cancer achieving complete response after chemoradiation.

García-Albéniz X, Gallego R, Hofheinz RD, Fernández-Esparrach G, Ayuso-Colella JR, Bombí JA, Conill C, Cuatrecasas M, Delgado S, Ginés A, Miquel R, Pagés M, Pineda E, Pereira V, Sosa A, Reig O, Victoria I, Feliz L, María de Lacy A, Castells A, Burkholder I, Hochhaus A, Maurel J.

World J Gastroenterol. 2014 Nov 14;20(42):15820-9. doi: 10.3748/wjg.v20.i42.15820.

36.

Updated guidelines for biomarker testing in colorectal carcinoma: a national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.

García-Alfonso P, García-Foncillas J, Salazar R, Pérez-Segura P, García-Carbonero R, Musulén-Palet E, Cuatrecasas M, Landolfi S, Ramón Y Cajal S, Navarro S; Spanish Society of Pathology; Spanish Society of Medical Oncology.

Clin Transl Oncol. 2015 Apr;17(4):264-73. doi: 10.1007/s12094-014-1252-0. Epub 2014 Nov 6.

PMID:
25373533
37.

Autoimmune pancreatitis type-1 associated with intraduct papillary mucinous neoplasm: report of two cases.

Vaquero EC, Salcedo MT, Cuatrecasas M, De León H, Merino X, Navarro S, Ginès A, Abu-Suboh M, Balsells J, Fernández-Cruz L, Molero X.

Pancreatology. 2014 Jul-Aug;14(4):316-8. doi: 10.1016/j.pan.2014.04.032. Epub 2014 May 9.

PMID:
25062884
38.

Whole-exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancer.

Esteban-Jurado C, Vila-Casadesús M, Garre P, Lozano JJ, Pristoupilova A, Beltran S, Muñoz J, Ocaña T, Balaguer F, López-Cerón M, Cuatrecasas M, Franch-Expósito S, Piqué JM, Castells A, Carracedo A, Ruiz-Ponte C, Abulí A, Bessa X, Andreu M, Bujanda L, Caldés T, Castellví-Bel S.

Genet Med. 2015 Feb;17(2):131-42. doi: 10.1038/gim.2014.89. Epub 2014 Jul 24. Erratum in: Genet Med. 2014 Dec;16(12):988-9.

39.

Accuracy of advanced endoscopy and fecal calprotectin for prediction of relapse in ulcerative colitis: a prospective study.

Jauregui-Amezaga A, López-Cerón M, Aceituno M, Jimeno M, Rodríguez de Miguel C, Pinó-Donnay S, Zabalza M, Sans M, Ricart E, Ordás I, González-Suárez B, Cuatrecasas M, Llach J, Panés J, Pellise M.

Inflamm Bowel Dis. 2014 Jul;20(7):1187-93. doi: 10.1097/MIB.0000000000000069.

PMID:
24874457
40.

RAC1b overexpression correlates with poor prognosis in KRAS/BRAF WT metastatic colorectal cancer patients treated with first-line FOLFOX/XELOX chemotherapy.

Alonso-Espinaco V, Cuatrecasas M, Alonso V, Escudero P, Marmol M, Horndler C, Ortego J, Gallego R, Codony-Servat J, Garcia-Albeniz X, Jares P, Castells A, Lozano JJ, Rosell R, Maurel J.

Eur J Cancer. 2014 Jul;50(11):1973-81. doi: 10.1016/j.ejca.2014.04.019. Epub 2014 May 12.

PMID:
24833563
41.

LINE-1 hypomethylation is neither present in rectal aberrant crypt foci nor associated with field defect in sporadic colorectal neoplasia.

Quintanilla I, Lopez-Cerón M, Jimeno M, Cuatrecasas M, Muñoz J, Moreira L, Carballal S, Leoz ML, Camps J, Castells A, Pellisé M, Balaguer F.

Clin Epigenetics. 2014 Nov 10;6(1):24. doi: 10.1186/1868-7083-6-24. eCollection 2014.

42.

The ZEB1 transcription factor acts in a negative feedback loop with miR200 downstream of Ras and Rb1 to regulate Bmi1 expression.

Liu Y, Sánchez-Tilló E, Lu X, Huang L, Clem B, Telang S, Jenson AB, Cuatrecasas M, Chesney J, Postigo A, Dean DC.

J Biol Chem. 2014 Feb 14;289(7):4116-25. doi: 10.1074/jbc.M113.533505. Epub 2013 Dec 26.

43.

Efficacy of erlotinib in patients with relapsed gliobastoma multiforme who expressed EGFRVIII and PTEN determined by immunohistochemistry.

Gallego O, Cuatrecasas M, Benavides M, Segura PP, Berrocal A, Erill N, Colomer A, Quintana MJ, Balaña C, Gil M, Gallardo A, Murata P, Barnadas A.

J Neurooncol. 2014 Jan;116(2):413-9. doi: 10.1007/s11060-013-1316-y. Epub 2013 Dec 19. Erratum in: J Neurooncol. 2014 Dec;120(3):667.

44.

Rb1 family mutation is sufficient for sarcoma initiation.

Liu Y, Sánchez-Tilló E, Lu X, Clem B, Telang S, Jenson AB, Cuatrecasas M, Chesney J, Postigo A, Dean DC.

Nat Commun. 2013;4:2650. doi: 10.1038/ncomms3650.

PMID:
24150016
45.

Level of HER2 gene amplification predicts response and overall survival in HER2-positive advanced gastric cancer treated with trastuzumab.

Gomez-Martin C, Plaza JC, Pazo-Cid R, Salud A, Pons F, Fonseca P, Leon A, Alsina M, Visa L, Rivera F, Galan MC, Del Valle E, Vilardell F, Iglesias M, Fernandez S, Landolfi S, Cuatrecasas M, Mayorga M, Jose Paulés M, Sanz-Moncasi P, Montagut C, Garralda E, Rojo F, Hidalgo M, Lopez-Rios F.

J Clin Oncol. 2013 Dec 10;31(35):4445-52. doi: 10.1200/JCO.2013.48.9070. Epub 2013 Oct 14.

PMID:
24127447
46.

Guidelines for biomarker testing in gastroenteropancreatic neuroendocrine neoplasms: a national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.

García-Carbonero R, Vilardell F, Jiménez-Fonseca P, González-Campora R, González E, Cuatrecasas M, Capdevila J, Aranda I, Barriuso J, Matías-Guiu X; Spanish Society of Pathology; Spanish Society of Medical Oncology.

Clin Transl Oncol. 2014 Mar;16(3):243-56. doi: 10.1007/s12094-013-1062-9. Epub 2013 Jun 8.

PMID:
23749327
47.

Sequential inductions of the ZEB1 transcription factor caused by mutation of Rb and then Ras proteins are required for tumor initiation and progression.

Liu Y, Sánchez-Tilló E, Lu X, Huang L, Clem B, Telang S, Jenson AB, Cuatrecasas M, Chesney J, Postigo A, Dean DC.

J Biol Chem. 2013 Apr 19;288(16):11572-80. doi: 10.1074/jbc.M112.434951. Epub 2013 Feb 26.

48.

Clinical subtypes and molecular characteristics of serrated polyposis syndrome.

Guarinos C, Sánchez-Fortún C, Rodríguez-Soler M, Pérez-Carbonell L, Egoavil C, Juárez M, Serradesanferm A, Bujanda L, Fernández-Bañares F, Cubiella J, de-Castro L, Guerra A, Aguirre E, Herreros-de-Tejada A, Bessa X, Herráiz M, Marín-Gabriel JC, Balmaña J, Cuatrecasas M, Balaguer F, Castells A, Soto JL, Alenda C, Payá A, Jover R.

Clin Gastroenterol Hepatol. 2013 Jun;11(6):705-11; quiz e46. doi: 10.1016/j.cgh.2012.12.045. Epub 2013 Jan 30.

PMID:
23376323
49.

ZEB1 Promotes invasiveness of colorectal carcinoma cells through the opposing regulation of uPA and PAI-1.

Sánchez-Tilló E, de Barrios O, Siles L, Amendola PG, Darling DS, Cuatrecasas M, Castells A, Postigo A.

Clin Cancer Res. 2013 Mar 1;19(5):1071-82. doi: 10.1158/1078-0432.CCR-12-2675. Epub 2013 Jan 22.

50.

Comparative study of NOTES alone versus NOTES guided by a new image registration system for navigation in the mediastinum: a study in a porcine model.

Córdova H, San José Estépar R, Rodríguez-D'Jesús A, Martínez-Pallí G, Arguis P, Rodríguez de Miguel C, Navarro-Ripoll R, Perdomo JM, Cuatrecasas M, Llach J, Vosburgh KG, Fernández-Esparrach G.

Gastrointest Endosc. 2013 Jan;77(1):102-7. doi: 10.1016/j.gie.2012.09.008.

Supplemental Content

Loading ...
Support Center